LivaNova (LIVN) Asset Writedowns and Impairment (2015 - 2026)
LivaNova (LIVN) reported Asset Writedowns and Impairment of $1.1 million for Q1 2026, up 201.8% sequentially from -$1.1 million in Q4 2025.
LivaNova (LIVN) Asset Writedowns and Impairment (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 9 years of Asset Writedowns and Impairment data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 6388.89% YoY), and the FY2023 full-year result was $12.6 million, changed N/A from the prior year.
- Asset Writedowns and Impairment rose to $1.1 million in Q1 2026, from -$1.1 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $12.6 million in Q4 2023 to a low of -$5.8 million in Q4 2024.
- A 4-year average of $2.3 million and a median of $1.1 million in 2025 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment sank 145.78% in 2024 and surged 80.72% in 2025, its largest moves.
- Tracing LIVN's Asset Writedowns and Impairment over 4 years: stood at $12.6 million in 2023, then slumped by 145.78% to -$5.8 million in 2024, then surged by 80.72% to -$1.1 million in 2025, then jumped by 201.8% to $1.1 million in 2026.
- Business Quant data shows LIVN's Asset Writedowns and Impairment at $1.1 million in Q1 2026, -$1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | -1.11 Mn |
| Dec 31, 2025 | -1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Dec 31, 2024 | -5.77 Mn |
| Dec 31, 2024 | -5.77 Mn |
| Jun 30, 2024 | 5.75 Mn |
| Jun 30, 2024 | 5.75 Mn |
| Dec 31, 2023 | 12.60 Mn |
| Dec 31, 2023 | 12.60 Mn |
| Dec 31, 2020 | 6.76 Mn |
| Dec 31, 2020 | 6.76 Mn |
| Dec 31, 2019 | 89.00 Mn |
| Dec 31, 2019 | 89.00 Mn |
| Jun 30, 2019 | 50.30 Mn |
| Jun 30, 2019 | 50.30 Mn |
| Dec 31, 2018 | 567,000.00 |
| Dec 31, 2018 | 567,000.00 |